Community pharmacist-administered injectable naltrexone for individuals who were formerly incarcerated: a review of Wisconsin legislation and regulations
Abstract Opioid use disorder (OUD) is highly prevalent among jail and prison populations in the United States, including in Wisconsin. Medications for opioid use disorder (MOUD), including long-acting injectable naltrexone, are crucial in the treatment of OUD. These medications are especially import...
Saved in:
| Main Authors: | Jason S. Chladek, Michelle A. Chui |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-04-01
|
| Series: | Substance Abuse Treatment, Prevention, and Policy |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s13011-025-00647-9 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Exploring strategies to connect formerly incarcerated individuals with community pharmacist-administered injectable naltrexone services
by: Jason S. Chladek, et al.
Published: (2025-07-01) -
RATIONALE FOR THE SELECTION OF AUXILIARY COMPONENTS FOR THE NALTREXONE HYDROCHLORIDE NASAL SPRAY
by: Y. M. Domnina, et al.
Published: (2019-01-01) -
Breaking Barriers: Empowering Cervical Cancer Screening with HPV Self-Sampling for Sex Workers and Formerly Incarcerated Women in Toronto
by: Mandana Vahabi, et al.
Published: (2024-12-01) -
Norskamerikanske bosetningsmønstre i Stoughton,
Wisconsin
by: Trond Espen Teigen Bjoland
Published: (2019-01-01) -
Lack of response of Chikungunya chronic infection with low-dose naltrexone: a case series
by: J. Carvalho
Published: (2024-04-01)